Concise Analysis of the International and China Blood Product Industry

March 6, 2014

DUBLIN, Mar. 06, 2014 /PRNewswire/ –

Research and Markets



) has announced the addition of the

“Concise Analysis of the International and China Blood Product Industry”

report to their offering.


Blood products are made by separating and extracting various proteins in plasma and classified into albumin products, immune globulin products, coagulation factor products and other blood products. China enterprises mainly produce nine kinds of products of the first three categories.

The concentration rate of global blood products is very high and the 5 enterprises of developed countries occupy 80-85% of the market. The global plasma volume in 2012 exceeded 30,000 tons and the market scale reached USD 17.5 billion, increasing by 7.4% YOY. The current global blood product market remains relatively stable, mainly driven by emerging economies.

There are strict regulations and high barriers to entry in China blood product industry. No new blood product manufacturing enterprises are allowed to be further established and the import of most blood product varieties is limited. By July 2013, there are only about 20 blood product manufacturers with normal production in China, with small annual plasma volumes and a low market concentration rate.

In 2012, China blood product enterprises realized a total plasma volume of 3,300 tons which decreased compared with that in 2011. The major reason was that the plasma-collecting volume of Guizhou Province accounted for nearly 30% of the total volume in China and the shut-down of many plasma stations in the province led to the drop of plasma volume in 2012.

Key Topics Covered:

1 Introduction of Blood Products

2 Overview on Global Blood Product Industry, 2008-2012

3 Development Environment of China Blood Product Industry, 2008-2013

4 Operation Status of China Blood Product Industry, 2008-2012

5 Top 5 Enterprises of China Blood Product Industry, 2010-2012

6 Prospect of China Blood Product Industry

Companies Mentioned:

    --  China National Biotec Group
    --  Hualan Biological Engineering
    --  Beijing Tiantan Biological Products
    --  Shanghai RAAS Blood Products
    --  Sichuan Yuanda Shuyang Pharmaceutical

For more information visit http://www.researchandmarkets.com/research/27pgqc/research_report

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

Source: PR Newswire

comments powered by Disqus